An autologous leukemia cell vaccine prevents murine acute leukemia relapse after cytarabine treatment-Reference-Cited by-同舟云学术

An autologous leukemia cell vaccine prevents murine acute leukemia relapse after cytarabine treatment

Published:2014-11-06 Issue:19 Volume:124 Page:2953-2963
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Gibbins John D.¹²^ORCID,Ancelet Lindsay R.¹^ORCID,Weinkove Robert¹³⁴^ORCID,Compton Benjamin J.⁵^ORCID,Painter Gavin F.⁵,Petersen Troels R.¹,Hermans Ian F.¹²^ORCID

Affiliation:

1. Malaghan Institute of Medical Research, Wellington, New Zealand;

2. School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand;

3. Capital and Coast District Health Board, Wellington Hospital, Wellington, New Zealand;

4. Department of Pathology and Molecular Medicine, University of Otago, Wellington, New Zealand; and

5. Ferrier Research Institute, Victoria University of Wellington, Petone, New Zealand

Abstract

Key Points A cellular vaccine incorporating the glycolipid α-galactosylceramide prevents relapse of acute leukemia following cytarabine chemotherapy.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/124/19/2953/1381600/2953.pdf

Reference75 articles.

1. Hematopoietic stem cell transplantation for acute myeloid leukemia: to whom, when, and how.;Magenau;Curr Oncol Rep,2013

2. High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study.;Terwijn;J Clin Oncol,2013

3. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.;Grimwade;Blood,2010

4. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.;Schlenk;N Engl J Med,2008

5. Use of allogeneic hematopoietic stem-cell transplantation based on minimal residual disease response improves outcomes for children with relapsed acute lymphoblastic leukemia in the intermediate-risk group.;Eckert;J Clin Oncol,2013

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. invariant Natural Killer T cell therapy as a novel therapeutic approach in hematological malignancies;Frontiers in Transplantation;2024-05-06

2. A Personalized Cancer Vaccine that Induces Synergistic Innate and Adaptive Immune Responses;Advanced Materials;2023-07-21

3. Dose-Dependent Effects in Plasma Oncotherapy: Critical In Vivo Immune Responses Missed by In Vitro Studies;Biomolecules;2023-04-21

4. Carrier-Free Nanoplatform via Evoking Pyroptosis and Immune Response against Breast Cancer;ACS Applied Materials & Interfaces;2022-12-20

5. Artesunate, a new antimalarial clinical drug, exhibits potent anti‐AML activity by targeting the ROS/Bim and TFRC/Fe ²⁺ pathways;British Journal of Pharmacology;2022-12-07